According to the Ministry of Food and Drug Safety on Wednesday, the ministry is working to designate glucagon-like peptide-1 obesity treatments as drugs of concern for abuse
Using these drugs results in a loss of muscle (remember, your heart is a muscle), bone density, and fat
Enhances Athletic Performance & Endurance
JAMA 295(15):18241830 Chen S, Zhou M, Sun J, Guo A, Fernando RL, Chen Y, Peng P, Zhao G, Deng Y (2019) DPP-4 inhibitor improves learning and memory deficits and AD-like neurodegeneration by modulating the GLP-1 signaling
Most patients tolerate Tirzepatide well, with the most common side effects being mild to moderate gastrointestinal symptoms, such as nausea or diarrhea